Alphatec Holdings Valuation Multiples

Alphatec Holdings Overview

About Alphatec Holdings

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.

Founded

2005

HQ

Employees

913

Website

atecspine.com

Sectors

Medical DevicesBioTechLongevity

Financials (LTM)

Revenue: $802M

EBITDA: $105M

EV

$2B

Valuation Multiples

Multiples.vc

Start free trial

Alphatec Holdings Financials

Alphatec Holdings reported last 12-month revenue of $802M and EBITDA of $105M.

In the same LTM period, Alphatec Holdings generated $562M in gross profit, $105M in EBITDA, and had net loss of ($118M).

Alphatec Holdings P&L

In the most recent fiscal year, Alphatec Holdings reported revenue of $764M and EBITDA of $93M.

Alphatec Holdings expects next 12-month revenue of XXX and NTM EBITDA of XXX

Alphatec Holdings Stock Performance

Alphatec Holdings has current market cap of $2B, and enterprise value of $2B.

Alphatec Holdings' stock price is $11.11.

Alphatec Holdings Valuation Multiples

Alphatec Holdings trades at 2.6x EV/Revenue multiple, and 20.1x EV/EBITDA.

Alphatec Holdings Financial Valuation Multiples

As of April 19, 2026, Alphatec Holdings has market cap of $2B and EV of $2B.

Equity research analysts estimate Alphatec Holdings' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Alphatec Holdings has a P/E ratio of (14.2x).

Alphatec Holdings Margins & Growth Rates

Alphatec Holdings' revenue in the last 12 month grew by 17%.

Alphatec Holdings' revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.6M for the same period.

Alphatec Holdings' rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Alphatec Holdings' rule of X is 57% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Alphatec Holdings Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Alphatec Holdings M&A Activity

Alphatec Holdings acquired XXX companies to date.

Last acquisition by Alphatec Holdings was on XXXXXXXX, XXXXX. Alphatec Holdings acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Alphatec Holdings Investment Activity

Alphatec Holdings invested in XXX companies to date.

Alphatec Holdings made its latest investment on XXXXXXXX, XXXXX. Alphatec Holdings invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).